EPFL scientists have developed a ligand molecule that connects peptide drugs to blood-serum albumin and keeps them from being cleared out by the kidneys too soon. The ligand is easy to synthesize and can extend the half-life of therapeutic peptides from minutes to several days.

This post comes from the RSS feed of EurekaAlert, you can find more here!

Written by admin